Literature DB >> 19945425

Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy.

Matthew E R Butchbach1, Ferrill F Rose, Sarah Rhoades, John Marston, John T McCrone, Rachel Sinnott, Christian L Lorson.   

Abstract

Proximal spinal muscular atrophy (SMA) is a leading genetic cause of infant death. Patients with SMA lose alpha-motor neurons in the ventral horn of the spinal cord which leads to skeletal muscle weakness and atrophy. SMA is the result of reduction in Survival Motor Neuron (SMN) expression. Transgenic mouse models of SMA have been generated and are extremely useful in understanding the mechanisms of motor neuron degeneration in SMA and in developing new therapeutic candidates for SMA patients. Several research groups have reported varying average lifespans of SMNDelta7 SMA mice (SMN2(+/+);SMNDelta7(+/+);mSmn(-/-)), the most commonly used mouse model for preclinical therapeutic candidate testing. One environmental factor that varied between research groups was maternal diet. In this study, we compared the effects of two different commercially available rodent chows (PicoLab20 Mouse diet and Harlan-Teklad 22/5 diet) on the survival and motor phenotype of the SMNDelta7 mouse model of SMA. Specifically, the PicoLab20 diet significantly extends the average lifespan of the SMNDelta7 SMA mice by approximately 25% and improved the motor phenotype as compared to the Harlan diet. These findings indicate that maternal diet alone can have considerable impact on the SMA phenotype. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945425      PMCID: PMC2839161          DOI: 10.1016/j.bbrc.2009.11.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.

Authors:  U R Monani; M Sendtner; D D Coovert; D W Parsons; C Andreassi; T T Le; S Jablonka; B Schrank; W Rossoll; W Rossol; T W Prior; G E Morris; A H Burghes
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

2.  Correlation between severity and SMN protein level in spinal muscular atrophy.

Authors:  S Lefebvre; P Burlet; Q Liu; S Bertrandy; O Clermont; A Munnich; G Dreyfuss; J Melki
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

Review 3.  Different data from different labs: lessons from studies of gene-environment interaction.

Authors:  Douglas Wahlsten; Pamela Metten; Tamara J Phillips; Stephen L Boehm; Sue Burkhart-Kasch; Janet Dorow; Sharon Doerksen; Chris Downing; Jennifer Fogarty; Kristina Rodd-Henricks; René Hen; Carrie S McKinnon; Catherine M Merrill; Cedar Nolte; Melike Schalomon; Jason P Schlumbohm; Jason R Sibert; Charlotte D Wenger; Bruce C Dudek; John C Crabbe
Journal:  J Neurobiol       Date:  2003-01

4.  Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

Authors:  P E McAndrew; D W Parsons; L R Simard; C Rochette; P N Ray; J R Mendell; T W Prior; A H Burghes
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 5.  Influence of food and diet on gastrointestinal drug absorption: a review.

Authors:  P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

6.  Patients with severe muscle wasting are prone to develop hypoglycemia during fasting.

Authors:  M C Ørngreen; M Zacho; A Hebert; M Laub; J Vissing
Journal:  Neurology       Date:  2003-10-14       Impact factor: 9.910

7.  Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.

Authors:  Luc Dupuis; Hugues Oudart; Frédérique René; Jose-Luis Gonzalez de Aguilar; Jean-Philippe Loeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

8.  Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Jasbir Singh; Margrét Thorsteinsdóttir; Luciano Saieva; Elzbieta Slominski; John Thurmond; Thorkell Andrésson; Jun Zhang; Jonathan D Edwards; Louise R Simard; Livio Pellizzoni; Jill Jarecki; Arthur H M Burghes; Mark E Gurney
Journal:  Hum Mol Genet       Date:  2009-11-06       Impact factor: 6.150

9.  Identification and characterization of a spinal muscular atrophy-determining gene.

Authors:  S Lefebvre; L Bürglen; S Reboullet; O Clermont; P Burlet; L Viollet; B Benichou; C Cruaud; P Millasseau; M Zeviani
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

10.  Hypoglycaemia in spinal muscular atrophy.

Authors:  A K Bruce; E Jacobsen; H Dossing; J Kondrup
Journal:  Lancet       Date:  1995-09-02       Impact factor: 79.321

View more
  27 in total

1.  The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice.

Authors:  Matthew E R Butchbach; Jasbir Singh; Mark E Gurney; Arthur H M Burghes
Journal:  Exp Neurol       Date:  2014-03-25       Impact factor: 5.330

2.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

3.  Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Casey J Lumpkin; Ashlee W Harris; Luciano Saieva; Jonathan D Edwards; Eileen Workman; Louise R Simard; Livio Pellizzoni; Arthur H M Burghes
Journal:  Exp Neurol       Date:  2016-02-15       Impact factor: 5.330

4.  Nutritional practices at a glance: spinal muscular atrophy type I nutrition survey findings.

Authors:  Rebecca Hurst Davis; Barbara J Godshall; Erin Seffrood; Mary Marcus; Bernard A LaSalle; Brenda Wong; Mary K Schroth; Kathryn J Swoboda
Journal:  J Child Neurol       Date:  2013-10-04       Impact factor: 1.987

5.  Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.

Authors:  Afrooz Rashnonejad; Gholamhossein Amini Chermahini; Cumhur Gündüz; Hüseyin Onay; Ayça Aykut; Burak Durmaz; Meral Baka; Qin Su; Guangping Gao; Ferda Özkınay
Journal:  Mol Ther       Date:  2019-08-31       Impact factor: 11.454

6.  Public attitudes regarding a pilot study of newborn screening for spinal muscular atrophy.

Authors:  Erin Rothwell; Rebecca A Anderson; Kathryn J Swoboda; Louisa Stark; Jeffrey R Botkin
Journal:  Am J Med Genet A       Date:  2013-02-26       Impact factor: 2.802

7.  Placental development in a mouse model of spinal muscular atrophy.

Authors:  Gerialisa Van Gronigen Caesar; Jeffrey M Dale; Erkan Y Osman; Michael L Garcia; Christian L Lorson; Laura C Schulz
Journal:  Biochem Biophys Res Commun       Date:  2015-12-31       Impact factor: 3.575

Review 8.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

9.  Observational study of caloric and nutrient intake, bone density, and body composition in infants and children with spinal muscular atrophy type I.

Authors:  Katherine E Poruk; Rebecca Hurst Davis; Abby L Smart; Benjamin S Chisum; Bernie A Lasalle; Gary M Chan; Gurmail Gill; Sandra P Reyna; Kathryn J Swoboda
Journal:  Neuromuscul Disord       Date:  2012-07-23       Impact factor: 4.296

10.  Glucose metabolism and pancreatic defects in spinal muscular atrophy.

Authors:  Melissa Bowerman; Kathryn J Swoboda; John-Paul Michalski; Gen-Sheng Wang; Courtney Reeks; Ariane Beauvais; Kelley Murphy; John Woulfe; Robert A Screaton; Fraser W Scott; Rashmi Kothary
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.